How is Xofluza (baloxavir marboxil) prescribed and what is the usual dosing?
Xofluza is an antiviral that is taken by mouth as a single dose for eligible people with flu. The typical approach is to prescribe one-time oral dosing based on the patient’s weight, given early in the course of influenza. Patients generally take it on their own using the provided tablets/suspension dosing instructions from the prescriber.
What does “the process” usually look like in practice?
In most cases, the workflow is:
A clinician confirms suspected influenza and checks whether the patient meets eligibility criteria (such as age and timing from symptom onset). If eligible, the clinician writes a prescription for Xofluza with the correct dose (often weight-based) and provides instructions for taking it as a single dose. The patient then takes the medication once and follows up if symptoms worsen or do not improve.
What happens if a person is outside the treatment window or has complications?
The main limiter for antivirals like Xofluza is when treatment starts after symptoms begin. If a patient presents later or has complications, clinicians may choose a different antiviral strategy or supportive care depending on severity and timing.
Who is Xofluza for, and what patient factors can change the dosing plan?
Clinicians consider factors such as:
age, weight, timing from symptom onset, and overall clinical status. These factors determine whether Xofluza is appropriate and what exact dose to prescribe.
If you share the patient’s age, weight, and when symptoms started, I can explain how clinicians typically decide the dosing and timing for Xofluza using the standard prescribing approach.
Sources
No sources were provided in your prompt.